These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

262 related articles for article (PubMed ID: 33846258)

  • 1. CCRL2 promotes antitumor T-cell immunity via amplifying TLR4-mediated immunostimulatory macrophage activation.
    Yin W; Li Y; Song Y; Zhang J; Wu C; Chen Y; Miao Y; Lin C; Lin Y; Yan D; Chen J; He R
    Proc Natl Acad Sci U S A; 2021 Apr; 118(16):. PubMed ID: 33846258
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Paclitaxel Reduces Tumor Growth by Reprogramming Tumor-Associated Macrophages to an M1 Profile in a TLR4-Dependent Manner.
    Wanderley CW; Colón DF; Luiz JPM; Oliveira FF; Viacava PR; Leite CA; Pereira JA; Silva CM; Silva CR; Silva RL; Speck-Hernandez CA; Mota JM; Alves-Filho JC; Lima-Junior RC; Cunha TM; Cunha FQ
    Cancer Res; 2018 Oct; 78(20):5891-5900. PubMed ID: 30104241
    [TBL] [Abstract][Full Text] [Related]  

  • 3.
    Hu L; Liu Y; Kong X; Wu R; Peng Q; Zhang Y; Zhou L; Duan L
    Front Immunol; 2021; 12():658681. PubMed ID: 34093546
    [No Abstract]   [Full Text] [Related]  

  • 4. An agonistic anti-Toll-like receptor 4 monoclonal antibody as an effective adjuvant for cancer immunotherapy.
    Tsukamoto H; Kubota K; Shichiku A; Maekawa M; Mano N; Yagita H; Ohta S; Tomioka Y
    Immunology; 2019 Oct; 158(2):136-149. PubMed ID: 31515801
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lactoferrin activates macrophages via TLR4-dependent and -independent signaling pathways.
    Curran CS; Demick KP; Mansfield JM
    Cell Immunol; 2006 Jul; 242(1):23-30. PubMed ID: 17034774
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Atypical Receptor CCRL2 Is Essential for Lung Cancer Immune Surveillance.
    Del Prete A; Sozio F; Schioppa T; Ponzetta A; Vermi W; Calza S; Bugatti M; Salvi V; Bernardini G; Benvenuti F; Vecchi A; Bottazzi B; Mantovani A; Sozzani S
    Cancer Immunol Res; 2019 Nov; 7(11):1775-1788. PubMed ID: 31484658
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Chlamydial heat shock protein 60 activates macrophages and endothelial cells through Toll-like receptor 4 and MD2 in a MyD88-dependent pathway.
    Bulut Y; Faure E; Thomas L; Karahashi H; Michelsen KS; Equils O; Morrison SG; Morrison RP; Arditi M
    J Immunol; 2002 Feb; 168(3):1435-40. PubMed ID: 11801686
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ginseng-derived nanoparticles alter macrophage polarization to inhibit melanoma growth.
    Cao M; Yan H; Han X; Weng L; Wei Q; Sun X; Lu W; Wei Q; Ye J; Cai X; Hu C; Yin X; Cao P
    J Immunother Cancer; 2019 Nov; 7(1):326. PubMed ID: 31775862
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Glucosylation endows nanoparticles with TLR4 agonist capability to trigger macrophage polarization and augment antitumor immunity.
    Liu L; Fu S; Zhu W; Cai Z; Cao Y; Huang Y; Yang L; Fu X; Jin R; Xia C; Zhang Y; Lui S; Gong Q; Song B; Wen L; Anderson JM; Ai H
    Biomaterials; 2024 Jan; 304():122424. PubMed ID: 38103347
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Anemoside A3 activates TLR4-dependent M1-phenotype macrophage polarization to represses breast tumor growth and angiogenesis.
    Yin L; Fan Z; Liu P; Chen L; Guan Z; Liu Y; Luo Y
    Toxicol Appl Pharmacol; 2021 Dec; 432():115755. PubMed ID: 34673087
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expression, regulation, and function of atypical chemerin receptor CCRL2 on endothelial cells.
    Monnier J; Lewén S; O'Hara E; Huang K; Tu H; Butcher EC; Zabel BA
    J Immunol; 2012 Jul; 189(2):956-67. PubMed ID: 22696441
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Toll-like receptor 4-dependent activation of macrophages by polysaccharide isolated from the radix of Platycodon grandiflorum.
    Yoon YD; Han SB; Kang JS; Lee CW; Park SK; Lee HS; Kang JS; Kim HM
    Int Immunopharmacol; 2003 Dec; 3(13-14):1873-82. PubMed ID: 14636836
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ficolin-2 triggers antitumor effect by activating macrophages and CD8
    Ding Q; Shen Y; Li D; Yang J; Yu J; Yin Z; Zhang XL
    Clin Immunol; 2017 Oct; 183():145-157. PubMed ID: 28844702
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Chemokine-like receptor 1 (CMKLR1) and chemokine (C-C motif) receptor-like 2 (CCRL2); two multifunctional receptors with unusual properties.
    Yoshimura T; Oppenheim JJ
    Exp Cell Res; 2011 Mar; 317(5):674-84. PubMed ID: 21056554
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Loss of fragile site-associated tumor suppressor promotes antitumor immunity via macrophage polarization.
    Zhang L; Zhang K; Zhang J; Zhu J; Xi Q; Wang H; Zhang Z; Cheng Y; Yang G; Liu H; Guo X; Zhou D; Xue Z; Li Y; Zhang Q; Da Y; Liu L; Yin Z; Yao Z; Zhang R
    Nat Commun; 2021 Jul; 12(1):4300. PubMed ID: 34262035
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impaired innate immunity in Tlr4(-/-) mice but preserved CD8+ T cell responses against Trypanosoma cruzi in Tlr4-, Tlr2-, Tlr9- or Myd88-deficient mice.
    Oliveira AC; de Alencar BC; Tzelepis F; Klezewsky W; da Silva RN; Neves FS; Cavalcanti GS; Boscardin S; Nunes MP; Santiago MF; Nóbrega A; Rodrigues MM; Bellio M
    PLoS Pathog; 2010 Apr; 6(4):e1000870. PubMed ID: 20442858
    [TBL] [Abstract][Full Text] [Related]  

  • 17. ESX Secretion-Associated Protein C From
    Guo Q; Bi J; Li M; Ge W; Xu Y; Fan W; Wang H; Zhang X
    Front Cell Infect Microbiol; 2019; 9():158. PubMed ID: 31134163
    [No Abstract]   [Full Text] [Related]  

  • 18. Vinblastine resets tumor-associated macrophages toward M1 phenotype and promotes antitumor immune response.
    Wang YN; Wang YY; Wang J; Bai WJ; Miao NJ; Wang J
    J Immunother Cancer; 2023 Aug; 11(8):. PubMed ID: 37652576
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nuclear factor translocation and acute anterior uveitis.
    Wang J; Lu H; Hu X; Chen W; Xu Z; Li S; Xu Y
    Mol Vis; 2011 Jan; 17():170-6. PubMed ID: 21264236
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Atractylenolide I modulates ovarian cancer cell-mediated immunosuppression by blocking MD-2/TLR4 complex-mediated MyD88/NF-κB signaling in vitro.
    Liu H; Zhang G; Huang J; Ma S; Mi K; Cheng J; Zhu Y; Zha X; Huang W
    J Transl Med; 2016 Apr; 14(1):104. PubMed ID: 27118139
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.